FDA approves once daily beta agonist, olodaterol
Striverdi Respimat, the long acting, long term once daily beta agonist, olodaterol from Boeringer Ingelheim used for treating COPD or Chronic Obstructive Pulmonary Disease and also includes patients of chronic ...